Back to Results
First PageMeta Content
CHOP / Progression-free survival


Updated Results of Phase 1b of Tarextumab (TRXT, OMP-59R5, anti-Notch 2/3) in Combination with Etoposide and Platinum Therapy (EP) in Patients (pts) with Untreated Extensive-Stage Small Cell Lung Cancer (ED-SCLC) Copies
Add to Reading List

Document Date: 2016-06-04 05:53:42


Open Document

File Size: 1,79 MB

Share Result on Facebook